FlexDex is a minimally invasive surgery medical device technology that provides high dexterity.
FlexDex has raised $13.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.
FlexDex's investors include National Science Foundation, Johnson & Johnson Innovation, Consensus Business Group, Almeda Ventures, Michigan Biomedical Venture Fund.
FlexDex is headquartered in Brighton, United States.
FlexDex is a minimally invasive surgery medical device technology that provides high dexterity.
FlexDex is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FlexDex — Funding & Investors." VCBacked, August 24, 2021, https://www.vcbacked.co/company/flexdex. Accessed August 14, 2026.
VCBacked. (2021). FlexDex — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/flexdex
{{cite web |title=FlexDex — Funding & Investors |url=https://www.vcbacked.co/company/flexdex |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated